A single-center, double-blind, randomized, placebo-controlled, two-arm study to evaluate the safety and efficacy of once-weekly sirolimus (rapamycin) on muscle strength and endurance in older adults following a 13-week exercise program

Brad Stanfield, Matt Kaeberlein, Brian Leroux, Julie Jones, Ruth Lucas, Bruce Arroll

Journal

Trials

DOI

10.1186/s13063-024-08490-2

Study type

randomized controlled trial

Population

older adults

View on DOI ↗